Key result
Post-stroke cognitive impairment significantly reduced adherence to medical recommendations (r=0.49, p<0.001), with 51.8% of all patients failing to comply with long-term therapy.
Cross-Sectional (n=56)
Yes
Effect estimate: r=0.49
p-value: p=<0.001
Post-stroke cognitive impairment is a significant barrier to treatment adherence, highlighting the need for cognitive evaluation to improve secondary stroke prevention.
Highlights cognitive screening as a potential tool to identify patients at risk for secondary prevention failure;.
Introduction. The effectiveness of secondary stroke prevention depends not only on the prescribed medications but also on patients’ compliance with doctors’ recommendations in general. Adherence to therapy among post-stroke patients remains insufficient. This is due to factors that negatively affect compliance with medical recommendations. Among those factors, post-stroke cognitive impairment deserves particular attention. Study aim – to identify the main factors that determine adherence to long-term therapy in patients after stroke and to assess the impact of post-stroke cognitive impairment on compliance with medical recommendations. Materials and methods. A total of 56 patients (mean age 64.67±10.19 years), who experienced a hemispheric ischaemic stroke 6 months ago, were examined. Cognitive function was evaluated using the Montreal Cognitive Assessment tool, the battery of tests to assess frontal dysfunction, drawing and clock copying tests, and tests of phonetic and semantic speech activity. Adherence to long-term therapy after stroke was determined using the Morisky–Green test. We also studied the role of sociodemographic and vascular risk factors, that determine treatment adherence. Results. More than half (51.8%) of post-stroke patients did not comply with medical recommendations. The main barriers to optimal adherence were the male gender, engagement in physical labour throughout life, and the presence of left ventricular hypertrophy, chronic heart failure or bad health habits. The presence of post-stroke cognitive impairment had a negative impact on the adherence to medical recommendations (r=0.49; p<0.001). The results of the survey showed that regular visits to medical specialists were one of the main requirements for maintaining optimal adherence to treatment. Most patients (59.6%) thought that forgetfulness is a key factor affecting adherence to therapy. Summary. Treatment adherence should be evaluated in all patients after stroke, especially in those with post-stroke cognitive impairment. The identification and correction of ‘modifiable’ risk factors is a way to increase adherence to treatment
No takes yet. Share an insight, caveat, or question.
А Н Боголепова (2019) conducted a cross-sectional in Post-stroke (n=56). Post-stroke cognitive impairment and sociodemographic factors vs. Absence of cognitive impairment and risk factors was evaluated on Adherence to long-term therapy (Morisky-Green test) (r=0.49, p=<0.001). Post-stroke cognitive impairment significantly reduced adherence to medical recommendations (r=0.49, p<0.001), with 51.8% of all patients failing to comply with long-term therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: